Evidence map›Paper›PMID 26932978›Full record

Observational studyBMJ (Clinical research ed.)2016

Primary prevention and risk factor reduction in coronary heart disease mortality among working aged men and women in eastern Finland over 40 years: population based observational study.

Pekka Jousilahti, Tiina Laatikainen, Markku Peltonen, Katja Borodulin, Satu Männistö, Antti Jula, Veikko Salomaa, Kennet Harald, Pekka Puska, Erkki Vartiainen

Open access · hybridAbstract readObservational Study
In one paragraph

Observational study in BMJ (Clinical research ed.), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 2 pooled it
21.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 2 syntheses or guidelines pooled it, 131 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Analysis of the association betweenFrontiers in cardiovascular medicine · 2026
    Article
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Implementation of the ESC STEMI guidelines in female and elderly patients over a 20-year period in a large German registry.Clinical research in cardiology : official journal of the German Cardiac Society · 2023
    Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Pekka JousilahtiNational Institute for Health and Welfare, Department of Health, PO Box 30, 00271 Helsinki, Finland pekka.jousilahti@thl.fi.
Tiina LaatikainenUniversity of Eastern Finland, Institute of Public Health and Clinical Nutrition, Kuopio, Finland.
Markku PeltonenNational Institute for Health and Welfare, Department of Health, PO Box 30, 00271 Helsinki, Finland.
Katja BorodulinNational Institute for Health and Welfare, Department of Health, PO Box 30, 00271 Helsinki, Finland.
Satu MännistöNational Institute for Health and Welfare, Department of Health, PO Box 30, 00271 Helsinki, Finland.
Antti JulaNational Institute for Health and Welfare, Department of Health, PO Box 30, 00271 Helsinki, Finland.
Veikko SalomaaNational Institute for Health and Welfare, Department of Health, PO Box 30, 00271 Helsinki, Finland.
Kennet HaraldNational Institute for Health and Welfare, Department of Health, PO Box 30, 00271 Helsinki, Finland.
Pekka PuskaNational Institute for Health and Welfare, Department of Health, PO Box 30, 00271 Helsinki, Finland.
Erkki VartiainenNational Institute for Health and Welfare, Department of Health, PO Box 30, 00271 Helsinki, Finland.
Finnish Institute for Health and Welfare · FIUniversity of Eastern Finland · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo estimate how much changes in the main risk factors of cardiovascular disease (smoking prevalence, serum cholesterol, and systolic blood pressure) can explain the reduction in coronary heart disease mortality observed among working aged men and women in eastern Finland.

designPopulation based observational study.

settingEastern Finland.

participants34,525 men and women aged 30-59 years who participated in the national FINRISK studies between 1972 and 2012.

interventionsChange in main cardiovascular risk factors through population based primary prevention.

main outcome measuresPredicted and observed age standardised mortality due to coronary heart disease. Predicted change was estimated with a logistic regression model using risk factor data collected in nine consecutive, population based, risk factor surveys conducted every five years since 1972. Data on observed mortality were obtained from the National Causes of Death Register.

resultsDuring the 40 year study period, levels of the three major cardiovascular risk factors decreased except for a small increase in serum cholesterol levels between 2007 and 2012. From years 1969-1972 to 2012, coronary heart disease mortality decreased by 82% (from 643 to 118 deaths per 100,000 people) and 84% (114 to 17) among men and women aged 35-64 years, respectively. During the first 10 years of the study, changes in these three target risk factors contributed to nearly all of the observed mortality reduction. Since the mid-1980s, the observed reduction in mortality has been larger than predicted. In the last 10 years of the study, about two thirds (69% in men and 66% in women) of the reduction could be explained by changes in the three main risk factors, and the remaining third by other factors.

conclusionReductions in disease burden and mortality due to coronary heart disease can be achieved through the use of population based primary prevention programmes. Secondary prevention among high risk individuals and treatment of acute events of coronary heart disease could confer additional benefit.

Indexed as

Primary PreventionAdultBiomarkersCholesterol, LDLCoronary Artery DiseaseFemaleFinlandFollow-Up StudiesHealth SurveysHumansHypercholesterolemiaHypertensionMaleMiddle AgedRegistriesRisk FactorsBiomarkersCholesterol, LDL

Identifiers

PMID26932978
PMCPMC4772739
OpenAlexW2289550600

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.